Cargando…
Ipilimumab as a Cause of Severe Pan-Colitis and Colonic Perforation
Ipilimumab is a human monoclonal antibody that functions as a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) inhibitor that is used to treat malignant melanoma. Due to ipilimumab’s removal of immune regulation, specifically through the inactivation of CTLA-4, it is commonly associated with inf...
Autores principales: | Shah, Raj, Witt, Danielle, Asif, Talal, Mir, Fahad F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438238/ https://www.ncbi.nlm.nih.gov/pubmed/28533998 http://dx.doi.org/10.7759/cureus.1182 |
Ejemplares similares
-
Ipilimumab-induced colonic perforation
por: Burdine, Lyle, et al.
Publicado: (2014) -
Ipilimumab- and Nivolumab-Induced Colitis Causing Severe Hypokalemia and QTc Prolongation
por: Anson, David, et al.
Publicado: (2019) -
Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis
por: Arriola, Edurne, et al.
Publicado: (2016) -
Infectious Colitis Associated With Ipilimumab Therapy
por: McCutcheon, Jessica L., et al.
Publicado: (2014) -
A case of spontaneous colonic perforation in collagenous colitis
por: Mori, Haruki, et al.
Publicado: (2019)